share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HERSHBERG ROBERT

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HERSHBERG ROBERT

Recursion Pharmaceuticals | 4:持股變動聲明-董事 HERSHBERG ROBERT
美股sec公告 ·  06/05 18:17
Moomoo AI 已提取核心訊息
Robert Hershberg, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock transaction on June 3, 2024. The transaction involved a grant of 13,097 shares of Class A Common Stock at no cost. Following the transaction, Hershberg's direct holdings in the company increased to a total of 51,716 shares. The grant is part of the company's compensation strategy and reflects the ongoing commitment to align the interests of its executives with those of shareholders.
Robert Hershberg, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock transaction on June 3, 2024. The transaction involved a grant of 13,097 shares of Class A Common Stock at no cost. Following the transaction, Hershberg's direct holdings in the company increased to a total of 51,716 shares. The grant is part of the company's compensation strategy and reflects the ongoing commitment to align the interests of its executives with those of shareholders.
與Recursion Pharmaceuticals,Inc. [RXRX]有關的Robert Hershberg於2024年6月3日完成了一筆股票交易。該交易涉及一次無償的13,097股A類普通股授予。交易後,Hershberg在該公司的直接持股增加至共51,716股。該授予是公司報酬策略的一部分,反映了公司與股東的利益一致的持續承諾。
與Recursion Pharmaceuticals,Inc. [RXRX]有關的Robert Hershberg於2024年6月3日完成了一筆股票交易。該交易涉及一次無償的13,097股A類普通股授予。交易後,Hershberg在該公司的直接持股增加至共51,716股。該授予是公司報酬策略的一部分,反映了公司與股東的利益一致的持續承諾。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息